Innovative cancer treatments that augment radiotherapy or chemotherapy by the use of immunotherapy or gene therapy

Rudolf Lucas, Yona Keisari

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Cancer is a complex multifactorial disease requiring combinations of several therapeutic modalities to treat it effectively. Despite advances in the field of prevention and treatment of cancer, morbidity and mortality remain high, especially for tumors that cannot be completely removed, as well as for those that are highly recurrent or highly metastatic. Surgery, radiotherapy and chemotherapy, alone or in combination, are currently the prevalent treatment modalities. Yet, in order to treat metastases more effectively, the immune response must be recruited. In this review, we will focus on recent patents in the field of cancer that have concentrated on combining chemotherapy or radiotherapy strategies with immunotherapy, in order to eradicate the primary tumor as well as its metastases.

Original languageEnglish (US)
Pages (from-to)201-208
Number of pages8
JournalRecent Patents on Anti-Cancer Drug Discovery
Volume1
Issue number2
DOIs
StatePublished - Dec 1 2006

Fingerprint

Genetic Therapy
Immunotherapy
Radiotherapy
Drug Therapy
Neoplasms
Neoplasm Metastasis
Therapeutics
Patents
Morbidity
Mortality

Keywords

  • Cancer
  • Chemotherapy
  • Combination therapy
  • Immunotherapy
  • Radiotherapy
  • Synergy

ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Cancer Research
  • Pharmacology (medical)

Cite this

Innovative cancer treatments that augment radiotherapy or chemotherapy by the use of immunotherapy or gene therapy. / Lucas, Rudolf; Keisari, Yona.

In: Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, No. 2, 01.12.2006, p. 201-208.

Research output: Contribution to journalReview article

@article{6638b0c458714a9ab64ec92e73c5a185,
title = "Innovative cancer treatments that augment radiotherapy or chemotherapy by the use of immunotherapy or gene therapy",
abstract = "Cancer is a complex multifactorial disease requiring combinations of several therapeutic modalities to treat it effectively. Despite advances in the field of prevention and treatment of cancer, morbidity and mortality remain high, especially for tumors that cannot be completely removed, as well as for those that are highly recurrent or highly metastatic. Surgery, radiotherapy and chemotherapy, alone or in combination, are currently the prevalent treatment modalities. Yet, in order to treat metastases more effectively, the immune response must be recruited. In this review, we will focus on recent patents in the field of cancer that have concentrated on combining chemotherapy or radiotherapy strategies with immunotherapy, in order to eradicate the primary tumor as well as its metastases.",
keywords = "Cancer, Chemotherapy, Combination therapy, Immunotherapy, Radiotherapy, Synergy",
author = "Rudolf Lucas and Yona Keisari",
year = "2006",
month = "12",
day = "1",
doi = "10.2174/157489206777442214",
language = "English (US)",
volume = "1",
pages = "201--208",
journal = "Recent Patents on Anti-Cancer Drug Discovery",
issn = "1574-8928",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Innovative cancer treatments that augment radiotherapy or chemotherapy by the use of immunotherapy or gene therapy

AU - Lucas, Rudolf

AU - Keisari, Yona

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Cancer is a complex multifactorial disease requiring combinations of several therapeutic modalities to treat it effectively. Despite advances in the field of prevention and treatment of cancer, morbidity and mortality remain high, especially for tumors that cannot be completely removed, as well as for those that are highly recurrent or highly metastatic. Surgery, radiotherapy and chemotherapy, alone or in combination, are currently the prevalent treatment modalities. Yet, in order to treat metastases more effectively, the immune response must be recruited. In this review, we will focus on recent patents in the field of cancer that have concentrated on combining chemotherapy or radiotherapy strategies with immunotherapy, in order to eradicate the primary tumor as well as its metastases.

AB - Cancer is a complex multifactorial disease requiring combinations of several therapeutic modalities to treat it effectively. Despite advances in the field of prevention and treatment of cancer, morbidity and mortality remain high, especially for tumors that cannot be completely removed, as well as for those that are highly recurrent or highly metastatic. Surgery, radiotherapy and chemotherapy, alone or in combination, are currently the prevalent treatment modalities. Yet, in order to treat metastases more effectively, the immune response must be recruited. In this review, we will focus on recent patents in the field of cancer that have concentrated on combining chemotherapy or radiotherapy strategies with immunotherapy, in order to eradicate the primary tumor as well as its metastases.

KW - Cancer

KW - Chemotherapy

KW - Combination therapy

KW - Immunotherapy

KW - Radiotherapy

KW - Synergy

UR - http://www.scopus.com/inward/record.url?scp=39049113003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049113003&partnerID=8YFLogxK

U2 - 10.2174/157489206777442214

DO - 10.2174/157489206777442214

M3 - Review article

C2 - 18221037

AN - SCOPUS:39049113003

VL - 1

SP - 201

EP - 208

JO - Recent Patents on Anti-Cancer Drug Discovery

JF - Recent Patents on Anti-Cancer Drug Discovery

SN - 1574-8928

IS - 2

ER -